Artiva Biotherapeutics Inc (ARTV)

08:30 AM

Cantor Fitzgerald reiterates Artiva Biotherapeutics stock rating By Investing.com - Investing.com Australia

08:30 AM

May 22, 2026

ARTV Stock Price, Quote & Chart | ARTIVA BIOTHERAPEUTICS INC (NASDAQ:ARTV) - ChartMill

May 22, 2026

May 21, 2026

Have Insiders Sold Artiva Biotherapeutics Shares Recently? - simplywall.st

May 21, 2026

May 21, 2026

Artiva Biotherapeutics CMO Subhashis Banerjee sells $63,386 in stock By Investing.com - Investing.com Nigeria

May 21, 2026

May 20, 2026

As Griffith retires, Dittrich returns to Amgen, takes CFO role - biocentury.com

May 20, 2026

May 20, 2026

Artiva Biotherapeutics COO Jennifer Bush sells $79,178 in stock By Investing.com - Investing.com Nigeria

May 20, 2026

May 20, 2026

Artiva names Diego Miralles as president and head of R&D - The Pharma Letter

May 20, 2026

May 20, 2026

Artiva Biotherapeutics CMO Subhashis Banerjee sells $63,386 in stock - Investing.com India

May 20, 2026

May 20, 2026

Artiva Biotherapeutics COO Jennifer Bush sells $79,178 in stock - Investing.com India

May 20, 2026

May 20, 2026

Artiva Biotherapeutics CEO Fred Aslan sells $244,252 of stock By Investing.com - Investing.com Nigeria

May 20, 2026

May 19, 2026

Artiva Biotherapeutics CEO Fred Aslan sells $244,252 of stock - Investing.com India

May 19, 2026

May 19, 2026

Artiva Biotherapeutics SVP Heather Raymon sells $27,879 in stock By Investing.com - Investing.com Australia

May 19, 2026

May 19, 2026

Artiva Biotherapeutics officer Christopher Horan sells $63,072 in stock - Investing.com India

May 19, 2026

May 19, 2026

Artiva Biotherapeutics SVP Heather Raymon sells $27,879 in stock - Investing.com India

May 19, 2026

May 19, 2026

Artiva Biotherapeutics officer Christopher Horan sells $63,072 in stock By Investing.com - Investing.com Australia

May 19, 2026

May 19, 2026

Artiva Biotherapeutics, Inc. to present five abstracts on AlloNK at EULAR 2026 across multiple diseases - Traders Union

May 19, 2026

May 19, 2026

Artiva Biotherapeutics announces executive changes and new appointments By Investing.com - Investing.com Nigeria

May 19, 2026

May 19, 2026

Artiva to present AlloNK therapy data at EULAR congress - Investing.com India

May 19, 2026

May 19, 2026

Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases - Yahoo Finance

May 19, 2026

May 19, 2026

Artiva Biotherapeutics appoints Diego Miralles as president, R&D head By Investing.com - Investing.com Nigeria

May 19, 2026

May 19, 2026

Artiva Biotherapeutics, Inc. Appoints New Principal Financial Officer and President in May 2026 - Minichart

May 19, 2026

May 19, 2026

Artiva Biotherapeutics announces executive changes and new appointments - Investing.com

May 19, 2026

May 19, 2026

Artiva Biotherapeutics Inc Thad Huston to separate as CFO effective May 22, 2026 - marketscreener.com

May 19, 2026

May 19, 2026

Artiva Biotherapeutics Inc Thad Huston To Separate As CFO Effective May 22, 2026 - TradingView

May 19, 2026

May 19, 2026

Artiva Biotherapeutics Names Diego Miralles, M.D., as Pres and Head of Research and Development >ARTV - Moomoo

May 19, 2026

May 19, 2026

Artiva Biotherapeutics Announces Major Executive Leadership Transitions - TipRanks

May 19, 2026

May 19, 2026

Artiva Biotherapeutics appoints Diego Miralles as president, R&D head - Investing.com

May 19, 2026

May 19, 2026

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, ... - Enidnews.com

May 19, 2026

May 19, 2026

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development - Yahoo Finance UK

May 19, 2026

May 15, 2026

Artiva Biotherapeutics (ARTV) price target increased by 60.00% to 27.74 - MSN

May 15, 2026

May 14, 2026

Major Insider Move Signals Big Confidence in Artiva Biotherapeutics - TipRanks

May 14, 2026

May 13, 2026

Ra Capital Management acquires $75m in Artiva Biotherapeutics shares By Investing.com - Investing.com Australia

May 13, 2026

May 13, 2026

Ra Capital Management acquires $75m in Artiva Biotherapeutics shares - Investing.com

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Needham Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Raises Target Price to $41 - Moomoo

May 12, 2026

May 11, 2026

TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating - Moomoo

May 11, 2026

May 11, 2026

Business News, Finance News, Stock Market - RTTNews

May 11, 2026

May 11, 2026

Cantor Fitzgerald Boosts Artiva Biotherapeutics (NASDAQ:ARTV) Price Target to $40.00 - MarketBeat

May 11, 2026

May 11, 2026

H.C. Wainwright raises Artiva Biotherapeutics price target to $35 - Investing.com

May 11, 2026

May 11, 2026

H.C. Wainwright raises Artiva Biotherapeutics price target to $35 By Investing.com - Investing.com Canada

May 11, 2026

May 11, 2026

Artiva Biotherapeutics stock slides despite positive trial data - MSN

May 11, 2026

May 10, 2026

Number of shareholders of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView

May 10, 2026

May 09, 2026

Artiva Biotherapeutics Announces $300 Million Equity Offering - The Globe and Mail

May 09, 2026

May 09, 2026

Artiva Biotherapeutics: Runway To Fund Operations Into 2Q 2027 >ARTV - Moomoo

May 09, 2026

May 09, 2026

Artiva Biotherapeutics Announces Underwriting Agreement and Public Offering of Shares and Pre-Funded Warrants - Minichart

May 09, 2026

May 08, 2026

Latham Watkins Advises on Artiva Biotherapeutics Offering of Common Stock and Pre Funded Warrants - Latham & Watkins LLP

May 08, 2026

May 08, 2026

Artiva reports clinical trial data for rheumatoid arthritis therapy - Investing.com UK

May 08, 2026

May 08, 2026

Artiva Biotherapeutics: 'Buy' On AlloNK POC And FDA Phase 3 Alignment For Refractory RA - Seeking Alpha

May 08, 2026